Total Funding
88
61
Total FundingConvertible Note raised
Growth Score 88 in past quarter
-5 pts
Heat Score 61 in past quarter
9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
29941
BioVentrix is a medical device company that improves and expands the treatment available for congestive heart failure.
- Arthur Bertolero: Co-founder and Director
- Lon S. Annest: VP of Medical Affairs & Co-Founder
About the Company
BioVentrix is a medical device company focusing on the treatment of congestive heart failure. Its mission is to improve and expand the treatment available for congestive heart failure (CHF) caused by ischemic cardiomyopathy through less invasive, catheter-based approaches.